Multiple Sclerosis, Relapsing-Remitting

Known as: Remitting Relapsing Multiple Sclerosis, Relapsing Remitting Multiple Sclerosis, Multiple Sclerosis, Remitting-Relapsing 
The most common clinical variant of MULTIPLE SCLEROSIS, characterized by recurrent acute exacerbations of neurologic dysfunction followed by partial… (More)

Topic mentions per year

Topic mentions per year

1978-2017
010020030019782017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2012
Highly Cited
2012
BACKGROUND BG-12 (dimethyl fumarate) was shown to have antiinflammatory and cytoprotective properties in preclinical experiments… (More)
Is this relevant?
Highly Cited
2010
Highly Cited
2010
BACKGROUND Oral fingolimod, a sphingosine-1-phosphate-receptor modulator that prevents the egress of lymphocytes from lymph nodes… (More)
  • figure 1
  • table 1
  • figure 2
  • table 3
  • table 3
Is this relevant?
Highly Cited
2010
Highly Cited
2010
BACKGROUND Fingolimod (FTY720), a sphingosine-1-phosphate-receptor modulator that prevents lymphocyte egress from lymph nodes… (More)
  • figure 1
  • table 1
  • figure 2
  • table 3
  • table 3
Is this relevant?
Highly Cited
2008
Highly Cited
2008
BACKGROUND There is increasing evidence that B lymphocytes are involved in the pathogenesis of multiple sclerosis, and they may… (More)
  • figure 1
  • table 1
  • table 1
  • table 2
  • table 3
Is this relevant?
Highly Cited
2008
Highly Cited
2008
We evaluated the safety, tolerability, pharmacodynamics, and activity of B-cell depletion with rituximab in patients with… (More)
Is this relevant?
Highly Cited
2005
Highly Cited
2005
A 46-year-old woman with relapsing-remitting multiple sclerosis died from progressive multifocal leukoencephalopathy (PML) after… (More)
  • table 1
  • figure 1
  • figure 2
Is this relevant?
Highly Cited
2004
Highly Cited
2004
Many drugs have been approved for relapsing forms of multiple sclerosis but are only partly effective, are injected, and are… (More)
Is this relevant?
Highly Cited
2002
Highly Cited
2002
Brain atrophy measured by MRI is a potentially useful tool for monitoring disease progression in multiple sclerosis. The location… (More)
Is this relevant?
Highly Cited
1998
Highly Cited
1998
It has been difficult to establish a strong correlation between total brain T2-weighted lesion volume on MRI and clinical… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • table 2
Is this relevant?
Highly Cited
1995
Highly Cited
1995
We studied copolymer 1 (Copaxone) in a multicenter (11-university) phase III trial of patients with relapsing-remitting multiple… (More)
Is this relevant?